Low Level laser Therapy (LLLT) Cold Laser - THOR Laser

Do More With A THOR

We make patients better quicker and cheaper with light

On Star Trek when someone is injured, they are taken to sick bay where the doctor uses a laser to heal the patient instantly. We make those (just not quite as instant).

The treatment is called Low Level Laser Therapy (LLLT) and is considered by many scientists to be "a new branch of medicine" (Dr Roberta Chow MD PhD).

Light (within certain parameters) can regenerate tissue, reduce inflammation and reduce pain. It does this by increasing cellular energy and reducing oxidative stress. These effects have been tested in over 300 clinical trials (RCT's) and thousands of laboratory studies and published in many leading journals including The Lancet, BMJ, Nature, PNAS, Spine, Muscle and Nerve, Pain, Stroke etc.

Dedicated private LLLT clinics are being born every month to meet public demand for pain relief and the former head of tissue viability for Scotland Lydia Jack demonstrated that the laser paid for itself with the first patient she treated.

Already THOR has over 3,000 customers in pioneering clinics and hospitals in 70 counties and is the only company with FDA, CE, TGA, Health Canada and NATO clearance to date.

VISION

Photomedicine in every department of every hospital, every doctor's office (clinic) and every home.

MISSION

Drug free pain relief and better healing through "best in class" photomedicine products and services.

VALUES

Our decisions and actions must work for all stakeholders;

James Carroll, Founder, CEO at THOR Photomedicine Ltd

The company is privately owned by founder and CEO James Carroll
James Carroll LinkedIn Profile
James Carroll papers

[top]



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

POSITIVE SYSTEMATIC REVIEWS PUBLISHED BY:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

REGULATORY APPROVALS INCLUDE:

Regulatory approvals include FDA, European CE mark, TGA Australia, Health Canada